SITC 2021 Registration Now Open Participate in person or virtually at the Society for Immunotherapy of Cancer’s (SITC) 36th Annual Meeting & Pre-Conference Programs (SITC 2021) taking place Nov. 10–14, 2021, at the Walter E. Washington Convention Center in Washington, D.C. Click here for more information about registering for SITC 2021.
SITC is seeking the best and brightest in the field to continue Dr. Rosenberg’s legacy with a research award for early career scientists focused on tackling challenges that face immunology and cancer immunotherapy. Nominations are due July 15.
SITC is pleased to announce the reinvigoration of the society’s innovative program designed to foster leadership development, collaborations and scientific exchange among early career investigators who are emerging leaders in the field of cancer immunotherapy: Sparkathon Accelerator: Emerging Leaders Igniting Innovation. Applications are due July 26 by 5 p.m. PDT.
Submit your Cutting-Edge Research
The deadline to submit research for a regular abstract, Young Investigator Award abstract and/or late-breaking abstract application is 5 p.m. PDT on July 29, 2021.
SITC Clinical Practice Guideline Webinar – Multiple MyelomaA free, hour-long webinar on cancer immunotherapy for multiple myeloma is coming up soon. Advance your understanding with practical management pearls and case-based learning led by expert panel authors from SITC’s clinical practice guideline on June 16 at 5 p.m. ET.
A series of eight two-hour online seminars will feature experts in a given subject area to provide an overview of the current scientific knowledge about an area of immunotherapy. An interactive Q&A session will follow the topic overview, providing attendees the opportunity to ask in-depth questions of the faculty as well as offering a forum for networking and initiation of collaborations with others working in a similar field.
Attend the SITC Interrogating the Tumor-Specific Surfaceome for Immune Targeting Workshop, Sept. 29–30, 2021, in San Diego. This SITC workshop will focus on the tumor cell surfaceome and the many opportunities that accompany it for the development of future immunotherapies and the maximization of existing techniques. Submit your research by 5 p.m. PDT on July 22.
Attend SITC's Bispecific T cell Engagers Workshop, Sept. 30–Oct. 1, 2021, in San Diego. This SITC workshop will focus on T cell engager biology and therapeutic strategies including target selection, therapeutic engineering and design features, cytotoxicity vs cytokine release, the impact of the tumor microenvironment, and advances in conditionally-active binding.
Comprised of several authoritative reviews of COVID-19 and Cancer Immunotherapy, this series, edited by Paolo Antonio Ascierto, MD and Jason D. Goldman, MD, MPH, will explore basic insights into the immunology of the novel coronavirus, repurposing of immune-based therapies including the effects of immune-oncology agents, and the affected cancer populations.
Attend SITC's Cytokines in Cancer Immunotherapy Workshop, Oct. 11–12, 2021, in New York. This SITC workshop will focus on providing a deeper understanding of cytokines in immune cell proliferation, differentiation, and function, as they pertain to tumor immunobiology and cancer immunotherapy approaches. Submit your research by 5 p.m. EDT on July 22.
Now Available: SITC Clinical Practice Guideline on Immunotherapy for the Treatment of Lymphoma
Join Alan Hutson, PhD, and the thousands of other cancer immunotherapy professionals who proudly call themselves SITC members.
New Online Patient Course Available: Understanding Cancer Immunotherapy Access SITC’s dedicated resource for patients and caregivers to learn about cancer immunotherapy
Explore resources and educational opportunities for cancer patients and those who advocate for them.
Track the latest advancements and educational opportunities in tumor immunology and cancer immunotherapy.
Advance science, submit your manuscript and monitor the global progress of cancer immunotherapy research.
June is Cancer Immunotherapy Month! Why not share Jim Allison: Breakthrough with your friends and family to celebrate the groundbreaking work by Dr. Allison and his team. Available on your favorite platforms for just 99 cents. If your institution ...
Enviado desde mi iPhone
Hi Muna, I work on PD-1-PD-L1 signaling in cancer and immunotherapy. I can definitely brain storm with you let me know if interested Sally Esmail Postdoctoral fellow Western University Canada ------------------------------ Sally Esmail PhD Postdoc ...
Donate today to support early career scientists who are emerging leaders seeking to advance research in the cancer immunotherapy field.
An open access, peer-reviewed journal, the Journal for ImmunoTherapy of Cancer (JITC) is the global voice of the society, producing original research articles, literature reviews and more on tumor immunology and cancer immunotherapy.
It is the mission of the Society for Immunotherapy of Cancer (SITC) to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation and leadership in the field. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: email@example.com